Loading...

ACAD ACADIA PHARMACEUTICALS INC Management Changes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2024 8-K

Show Summary

Show Summary

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

Brendan Teehan, COO of Acadia Pharmaceuticals, was terminated without cause but will assist in the transition until December 31, 2024, with responsibilities taken over by CEO Catherine Owen Adams.

AI Assistant

ACADIA PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.